Fraudulent Blood-Testing Firm Theranos, Which Is Still Somehow a Company, Will Soon Be No More

Theranos, the fraudulent blood-testing startup which despite an incredible amount of wrongdoing has managed to remain an extant corporate entity until now, will soon dissolve. Read More >>

Theranos Offers More Worthless Stock to Investors Who Pinky Swear Not to Sue

The Wall Street Journal has yet another essential report from inside the meltdown of biomedical company Theranos. The company, which is currently the subject of a criminal probe for allegedly misleading investigators and government investigators, is reportedly offering investors more shares in exchange for a promise not to sue them. Read More >>

Wait and Bleed: Theranos Drains Henry Kissinger and Others From Leadership

Two months after sketchy blood-testing startup Theranos revealed it was closing all of its labs and firing hundreds of employees, the company announced a new round of bloodletting on Thursday with the “retirement” of its board of counsellors made up of former high-ranking government officials. Read More >>

Newspaper That Brought Down Theranos Learns Owner Is Major Investor

Once upon a time, Theranos was a promising biotech firm—raising $632 million from 2014-2015. In October 2015, everything changed when the Wall Street Journal published the first of its many exposés that revealed the company’s struggle to develop the blood-testing technology it promised. Read More >>

Blood Testing Company Told to Prove Reliability of it Blood Tests

Elizabeth Holmes, the beleaguered founder-and-chief of Theranos, has agreed to publish scientific data that will supposedly affirm the accuracy and reliability of its blood tests. But as a recent inspection report from the US's Food and Drug Administration (FDA) points out, things don’t look good. Read More >>